Medtronic to acquire SPR Therapeutics for $650 million

May 20, 2026 9:15 AM

Medtronic plc (NYSE: MDT) announced its intent to acquire SPR Therapeutics, Inc. for approximately $650 million in cash, according to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found